Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 1
2018 1
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Preventing Infections in Children with Cancer.
Lighter-Fisher J, Stanley K, Phillips M, Pham V, Klejmont LM. Lighter-Fisher J, et al. Among authors: klejmont lm. Pediatr Rev. 2016 Jun;37(6):247-58. doi: 10.1542/pir.2015-0059. Pediatr Rev. 2016. PMID: 27252180 Review. No abstract available.
A pilot safety, feasibility and efficacy study of an oral anticoagulant, apixaban, in secondary prophylaxis of a primary venous thromboembolism in children and adolescents.
Pinchinat A, Levendoglu-Tugal O, Perez Y, Thatcher E, Otero N, Budhram A, Mahanti H, Morris E, Klejmont L, Schaefer E, Brudnicki A, Friedman D, Li S, Cairo MS. Pinchinat A, et al. Among authors: klejmont l. Br J Haematol. 2023 Jun;201(5):e54-e57. doi: 10.1111/bjh.18804. Epub 2023 Apr 12. Br J Haematol. 2023. PMID: 37042190 No abstract available.
A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma.
Goldman S, Barth M, Shiramizu B, Shi Q, Hochberg J, Klejmont L, Harrison L, Basso J, Chu Y, Islam H, Gerard P, Agsalda-Garcia M, Shieh T, Oesterheld J, Heym K, Kirov I, Drachtman R, Harker-Murray P, Perkins S, Miles RR, Cairo M. Goldman S, et al. Among authors: klejmont l. Leukemia. 2021 Oct;35(10):2994-2997. doi: 10.1038/s41375-021-01256-8. Epub 2021 May 3. Leukemia. 2021. PMID: 33941850 No abstract available.
Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II, non-randomized controlled trial.
Hochberg J, Basso J, Shi Q, Klejmont L, Flower A, Bortfeld K, Harrison L, van de Ven C, Moorthy C, Islam H, Gerard P, Voss S, Cairo MS. Hochberg J, et al. Among authors: klejmont l. J Immunother Cancer. 2022 May;10(5):e004445. doi: 10.1136/jitc-2021-004445. J Immunother Cancer. 2022. PMID: 35584865 Free PMC article. Clinical Trial.
Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.
Friedman D, Dozor AJ, Milner J, D'Souza M, Talano JA, Moore TB, Shenoy S, Shi Q, Walters MC, Vichinsky E, Parsons SK, Braniecki S, Moorthy CR, Ayello J, Flower A, Morris E, Mahanti H, Fabricatore S, Klejmont L, van de Ven C, Baxter-Lowe LA, Cairo MS. Friedman D, et al. Among authors: klejmont l. Bone Marrow Transplant. 2021 Sep;56(9):2221-2230. doi: 10.1038/s41409-021-01298-7. Epub 2021 May 6. Bone Marrow Transplant. 2021. PMID: 33958740 Free PMC article.
Risk Factors Associated with Survival Following Ganciclovir Prophylaxis through Day +100 in Cytomegalovirus At-Risk Pediatric Allogeneic Stem Cell Transplantation Recipients: Development of Cytomegalovirus Viremia Associated with Significantly Decreased 1-Year Survival.
Klejmont LM, Mo X, Milner J, Harrison L, Morris E, van de Ven C, Cairo MS. Klejmont LM, et al. Transplant Cell Ther. 2024 Jan;30(1):103.e1-103.e8. doi: 10.1016/j.jtct.2023.09.025. Epub 2023 Oct 6. Transplant Cell Ther. 2024. PMID: 37806447